订阅小程序
旧版功能

A Phase I Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of Mrna-4157 Alone in Patients with Resected Solid Tumors and in Combination with Pembrolizumab in Patients with Unresectable Solid Tumors.

Howard A. Burris,Manish R. Patel,Daniel C. Cho,Jeffrey Melson Clarke,Martin Gutierrez,Tal Z. Zaks,Joshua Frederick,Kristen Hopson,Kinjal Mody,Alverina Binanti-Berube,Celine Robert-Tissot, Bree Goldstein, Ben Breton,Jing Sun,Shan Zhong,Scott K. Pruitt,Karen Keating,Robert S. Meehan,Justin F. Gainor

Journal of Clinical Oncology（2019）

引用 102|浏览76
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要